Diabetes and COVID-19: Short- and Long-Term Consequences.

Area of Science:

• Infectious Diseases
• Metabolic Disorders
• Public Health

Background:

• Metabolic diseases, particularly diabetes, are linked to increased COVID-19 severity and mortality.
• SARS-CoV-2 infection can exacerbate metabolic conditions and trigger new-onset disorders.
• Individuals with diabetes experience heightened risks during acute COVID-19, long-COVID, and reinfections.

Purpose of the Study:

• To review the elevated risk of severe COVID-19 and long-COVID in patients with diabetes.
• To explore the mechanisms underlying increased COVID-19 severity in diabetic populations.
• To discuss the impact of pandemic-related lockdowns on glycemic control.

Main Methods:

• Literature review of studies on COVID-19 and diabetes.
• Analysis of data concerning acute COVID-19, long-COVID, and metabolic complications.
• Examination of research on vaccine breakthrough infections and reinfections in diabetic patients.

Main Results:

• Diabetic patients exhibit a significantly higher risk for severe COVID-19 outcomes and mortality.
• COVID-19 infection can lead to worsening of metabolic diseases and new-onset metabolic disorders.
• Lockdown measures have demonstrably affected glycemic control in individuals with diabetes.

Conclusions:

• Diabetes is a critical risk factor for severe COVID-19, long-COVID, and related mortality.
• Further research is essential to fully elucidate the complex interplay between SARS-CoV-2 and metabolic health.
• Understanding these mechanisms is crucial for developing targeted interventions and improving patient outcomes.